Abstract
India is an increasingly attractive destination for R&D activities in the
pharmaceutical and biotechnology industry. Being an emerging market, companies
face a number of unique hurdles before entering this lucrative region.
The report provides an overview of the Indian pharma and biotech market, and
answers the following key questions:
- Who are the key players in the Indian pharmaceutical market?
- How has the Indian regulatory environment changed?
- What R&D collaborative opportunities are available?
- How can companies engage with India for collaboration?
- What are the leading R&D companies in India doing in collaborative R&D?
Readers will gain an analysis of the regulatory environment, insights into
collaborative opportunities and detailed information on the key companies,
clusters and government initiatives.
This report is a valuable resource for use by all those developing company
strategy and direction in this key emerging market.
'India: Pharmaceutical and biotechnology opportunities' is based on the
December 2004 report 'India: The emerging R&D collaborative opportunity'. The
new report includes additional sections on the Indian Patents Act 2005, the
Indian pharmaceutical policy, an overview of Department of Biotechnology
initiatives, including details of biotechnology parks, and an all-new set of
profiles on life science research institutes.
The profiles section of 'India: Pharmaceutical and biotechnology
opportunities' contains updated profiles and contact details on key companies.
| 
View Cart
